In vivo biocompatibility evaluation of electrospun composite scaffolds by subcutaneous implantation in rat

Drug Delivery and Translational Research
Amit K JaiswalGeeta R Vanage

Abstract

In vivo biocompatibility of nanofibrous poly-L-lactic acid (P), poly-L-lactic acid/gelatin (PG), poly-L-lactic acid/hydroxyapatite (PH), and poly-L-lactic acid/gelatin/hydroxyapatite (PGH) scaffolds, useful in regenerative medicine and drug delivery, was evaluated by subcutaneous implantation in both male and female rats (n = 5) for up to 90 days. The body weight of each animal in the study was evaluated on a weekly basis, and no significant difference was noticed. Total and differential leukocyte counts displayed no inflammatory reaction due to scaffold implantation. Gross observation and histology of necropsied vital organs exhibited normal morphology of cell types and tissue, denying any systemic adverse reaction on distal organs. Histology of subcutaneous tissue surrounding scaffolds was done to assess any local toxic effect of implants and found all scaffolds to be compatible and nontoxic. Moreover, no remnant of scaffolds was observed in any of the histological sections, suggesting all scaffolds to be biodegradable. All the results in this study confirm that nanofibrous scaffolds P, PG, PH, and PGH are biocompatible and safe for bone tissue engineering application.

References

Dec 1, 1992·Journal of Biomedical Materials Research·Y MatsusueY Ikada
Mar 1, 1983·Journal of Biomedical Materials Research·S R Taylor, D F Gibbons
Dec 1, 1995·Journal of Biomedical Materials Research·J H BraukerR C Johnson
Sep 1, 1996·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·M H HofbauerM L Scripps
Jun 11, 1998·Trends in Biotechnology·B S Kim, D J Mooney
Jun 21, 2001·ANZ Journal of Surgery·W R MooreG I Bain
Feb 19, 2008·Biomaterials·Travis J Sill, Horst A von Recum
May 27, 2008·Biomaterials·Yongzhong WangDavid L Kaplan
Aug 13, 2009·Biomedical Materials·Sung Eun KimIl Keun Kwon
Jun 25, 2010·Journal of Biomedical Materials Research. Part a·Jinku KimLichun Lu
Oct 13, 2011·BioTechniques·Ryan M BoehlerLonnie D Shea
Apr 3, 2012·Journal of Biomedical Materials Research. Part a·Bit Na LeeMoon Suk Kim

❮ Previous
Next ❯

Citations

Aug 12, 2017·Neurourology and Urodynamics·Mahshid VashaghianJan-Paul Roovers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.